Takeda Pharmaceutical is to acquire the Brazilian branded generics and OTC drug company Multilab Indústria e Comércio de Produtos Farmacêuticos for BRL500 M (US$246 M) upfront and up to BRL40 M (US$20 M) in future milestone payments. Multilab’s products include Multigrip®, the best-selling OTC cold and flu remedy in Brazil, and will augment Takeda’s existing OTC portfolio in the country, which it gained via its 2011 acquisition of Nycomed.